Purdue Institute for Drug Discovery

EV25

Overview: 

EV25 is an anti-influenza drug that recruits immune cells to kill virally-infected cells.  This results in faster clearance of the infection and EV25 is more potent than the current standard of care anti-influenza drugs

Status: 

Purdue Faculty: 

Dr. Phil Low

Development Partner: 

Eradivir